JP2024535896A5 - - Google Patents
Info
- Publication number
- JP2024535896A5 JP2024535896A5 JP2024518237A JP2024518237A JP2024535896A5 JP 2024535896 A5 JP2024535896 A5 JP 2024535896A5 JP 2024518237 A JP2024518237 A JP 2024518237A JP 2024518237 A JP2024518237 A JP 2024518237A JP 2024535896 A5 JP2024535896 A5 JP 2024535896A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- present specification
- invention described
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163246902P | 2021-09-22 | 2021-09-22 | |
| US63/246,902 | 2021-09-22 | ||
| US202263320187P | 2022-03-15 | 2022-03-15 | |
| US63/320,187 | 2022-03-15 | ||
| PCT/US2022/044400 WO2023049272A1 (en) | 2021-09-22 | 2022-09-22 | Coronavirus vaccines and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535896A JP2024535896A (ja) | 2024-10-02 |
| JP2024535896A5 true JP2024535896A5 (enExample) | 2025-10-01 |
Family
ID=83902994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518237A Withdrawn JP2024535896A (ja) | 2021-09-22 | 2022-09-22 | コロナウイルスのワクチンと使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20260207734A1 (enExample) |
| EP (1) | EP4404960A1 (enExample) |
| JP (1) | JP2024535896A (enExample) |
| CN (1) | CN119768180A (enExample) |
| AU (1) | AU2022350653A1 (enExample) |
| CA (1) | CA3232870A1 (enExample) |
| TW (1) | TW202330020A (enExample) |
| WO (1) | WO2023049272A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2023094713A2 (en) * | 2021-11-29 | 2023-06-01 | BioNTech SE | Coronavirus vaccine |
| US11878055B1 (en) | 2022-06-26 | 2024-01-23 | BioNTech SE | Coronavirus vaccine |
| CN121752291A (zh) * | 2023-06-30 | 2026-03-27 | 思齐乐私人有限公司 | SARS-CoV-2 RNA疫苗及其用途 |
| FR3155424A1 (fr) | 2023-11-15 | 2025-05-23 | BioNTech SE | Compositions immunogènes contre le sars-cov-2 |
| CN119770495B (zh) * | 2025-01-10 | 2026-06-30 | 厦门大学附属第一医院(厦门市第一医院、厦门市红十字医院、厦门市糖尿病研究所) | 一种改善或治疗滤泡淋巴瘤的联合用药物组合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| IL106610A0 (en) | 1992-08-07 | 1993-12-08 | Cytel Corp | Hla binding peptides and their uses |
| SG49008A1 (en) | 1993-03-05 | 1998-05-18 | Cytel Corp | Hla-a2.1 binding peptides and their uses |
| WO2012159643A1 (en) | 2011-05-24 | 2012-11-29 | Biontech Ag | Individualized vaccines for cancer |
-
2022
- 2022-09-22 CA CA3232870A patent/CA3232870A1/en active Pending
- 2022-09-22 EP EP22793268.8A patent/EP4404960A1/en not_active Withdrawn
- 2022-09-22 JP JP2024518237A patent/JP2024535896A/ja not_active Withdrawn
- 2022-09-22 WO PCT/US2022/044400 patent/WO2023049272A1/en not_active Ceased
- 2022-09-22 CN CN202280077261.6A patent/CN119768180A/zh active Pending
- 2022-09-22 AU AU2022350653A patent/AU2022350653A1/en active Pending
- 2022-09-22 US US18/694,596 patent/US20260207734A1/en active Pending
- 2022-09-22 TW TW111135962A patent/TW202330020A/zh unknown